AAR is a provider of products and services to the aviation and government and defense markets. The company reports its activities in two business segments: Aviation Services and Expeditionary Services. The Aviation Services segment provides aftermarket support and services for the commercial aviation and government and defense markets. In this segment, the company also provides inventory management and distribution services, maintenance, repair and overhaul, and engineering services. The Expeditionary Services segment consists of businesses that primarily provide products and services supporting the movement of equipment and personnel by the U.S. and foreign governments and non-governmental organizations.

Crocs is engaged in the design, development, marketing, distribution, and sale of casual lifestyle footwear and accessories for men, women, and children. The company provides a variety of footwear products including sandals, flips and slides, which the company collectively refer to as sandals, shoes, and boots. The majority of shoes within the company's collection contains Croslite? material. The company's wholesale channel includes domestic and international multi-brand retailers, e-tailers, and distributors; the company's retail channel consists of company-operated stores; and the company's e-commerce channel includes company-operated e-commerce sites and third-party marketplaces.

Helen of Troy is a designer, developer, importer, marketer, and distributor of a portfolio of brand-name consumer products. The company operates three segments: Housewares, which includes food preparation tools and storage containers, cleaning, bath and garden tools and accessories, infant and toddler care products, and insulated beverage and food containers; Health and Home, which focuses on healthcare devices such as thermometers, humidifiers, heating pads, water filtration systems, and small home appliances; and Beauty, which includes electric hair care, beauty care and wellness appliances, grooming tools and accessories, and liquid-, solid- and powder-based personal care and grooming products.

Intel is a data-centric company. The company's operating segments are: Data Center Group, which develops platforms for compute, storage, and network functions; Internet of Things Group, which facilitates its customers creating, storing, and processing data; Mobileye, which provides assistance and automation solutions; Non-Volatile Memory Solutions Group, which provides memory and storage products based on Intel? Optane? technology and Intel? 3D NAND technology; Programmable Solutions Group, which provides programmable semiconductors; and Client Computing Group, which connects people to data, allowing each person to focus, create, and engage in ways that unlock their individual potential.

Jack in the Box operates and franchises Jack in the Box? quick-service restaurants (QSRs). Jack in the Box restaurants provide a selection of products including burgers like its Jumbo Jack? and product lines such as Buttery Jack? burgers. The company also provides breakfast sandwiches with cracked eggs, tacos and curly fries, along with sandwiches, salads and real ice cream shakes, among other items. The company allows its guests to customize their meals and order any product, including breakfast items any time of the day (or night). The company operates and franchises Jack in the Box QSRs, primarily in the western and southern United States, including in Guam.

Kura Oncology is a clinical-stage biopharmaceutical company engaged in developing medicines for the treatment of cancer. The company's key product candidate, tipifarnib, is a selective and orally bioavailable inhibitor of farnesyl transferase. The company's second product candidate is KO-947, a selective small molecule inhibitor of extracellular signal related kinase, which the company is developing as a potential treatment for patients with tumors that have dysregulated activity due to mutations or other mechanisms in the mitogen-activated protein kinase pathway. The company's third product candidate is KO-539, a selective small molecule inhibitor of the menin-mixed lineage leukemia, protein-protein interaction.

Zafgen is a biopharmaceutical company that has utilized its proprietary methionine aminopeptidase 2, or MetAP2, biology platform to develop the study of MetAP2 inhibitors in both common and rare metabolic disorders.

LightPath Technologies manufactures optical components and assemblies, including precision molded glass aspheric optics, molded and diamond-turned infrared aspheric lenses and other optical materials used to produce products that manipulate light. The company designs, develops, manufactures and distributes optical components and assemblies utilizing optical manufacturing processes. The company's products are incorporated into sqveral applications. These applications include defense and medical devices, laser aided industrial tools, automotive safety applications, barcode scanners, optical data storage, hybrid fiber coax datacom, telecommunication optical networks, machine vision and sensors, among others.

Mercury Systems is a commercial provider of sensor and safety processing subsystems. The company delivers solutions for a range of aerospace, commercial aviation, defense and intelligence programs. The company's products and solutions have been deployed in various programs with different defense prime contractors. The company's technologies and capabilities include embedded processing modules and subsystems, mission computers, rack-mount servers, avionics, radio frequency components, multi-function assemblies and subsystems. The company delivers subsystem level engineering capability and ongoing systems integration services to the subsystem market within the defense embedded electronics market segment.

Scholar Rock is a biopharmaceutical company. The company's primary product candidate, SRK-015, is a selective, fully human, monoclonal antibody, with a mechanism of action that results in inhibition of the activation of the growth factor, myostatin, in skeletal muscle. The company's second product candidate is SRK-181 and is being developed for the treatment of cancers resistant to checkpoint blockade therapies, such as anti-PD1 antibodies. The company's third antibody program targets the signaling of bone morphogenetic protein 6, another member of the TGF? superfamily, which is involved in a set of biological processes in various parts of the body.

Scholastic is a publisher and distributor of children's books, a provider of print and digital instructional materials for pre-kindergarten to grade 12, and a producer of educational and entertaining children's media. The company creates books and ebooks, print and technology-based learning materials and programs, classroom magazines and other products that, in combination, provides schools, as well as parents and children, solutions to support children's learning and reading both at school and at home. The company is the operator of school-based book clubs and book fair proprietary channels. It distributes its products and services through these channels, as well as directly to schools and libraries.

Stoke Therapeutics is a biotechnology company focused on treating the underlying causes of severe genetic diseases by upregulating protein expression. The company is developing antisense oligonucleotide, medicines that target ribonucleic acid (RNA), and modulate precursor-messenger RNA, splicing to upregulate protein expression where needed and with appropriate specificity to near normal levels. The company designed its primary product candidate, STK-001, to treat Dravet syndrome, a severe and progressive genetic epile.

United Natural Foods is a distributor of natural, organic, specialty, produce, and grocery and non-food products, and provider of support services in the United States and Canada. The company's selection of products includes nationally advertised brand name and private-label products, including grocery, general merchandise, home, health and beauty care, and pharmacy, which are sold through its Wholesale segment to wholesale customers and through its subsidiary, SUPERVALU INC.'s-operated retail stores to shoppers. The company provides marketing services for its customers and suppliers, including consumer and trade marketing programs, as well as programs to support suppliers in understanding its markets.

Xencor is a clinical-stage biopharmaceutical company focused on discovering and developing engineered monoclonal antibody and other protein therapeutics to treat diseases with unmet medical needs. The company is developing a suite of clinical-stage drug candidates from its proprietary XmAb? technology platforms that are designed to treat cancer and autoimmune diseases. The company's protein engineering knowledge and the XmAb technologies are focused on the parts of the antibody that interacts with various segments of the immune system and controls antibody structure. This segment, referred to as the Fc domain, is constant and interchangeable among antibodies.